Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a -11.571% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
(a) CCN1CCCC1CNC(=O)c1cc([N+](=O)[O-])c(N(C)C)cc1OC
(b) CCCc1cc(=O)oc2cc(OC(=O)CN3C(=O)NC4(CCCC4)C3=O)ccc12
Answer: b. CCCc1cc(=O)oc2cc(OC(=O)CN3C(=O)NC4(CCCC4)C3=O)ccc12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCc1cc(=O)oc2cc(OC(=O)CN3C(=O)NC4(CCCC4)C3=O)ccc12
CCCc1cc(=O)oc2cc(OC(=O)CN3C(=O)NC4(CCCC4)C3=O)ccc12
(2-oxo-4-propylchromen-7-yl) 2-(2,4-dioxo-1,3-diazaspiro[4.4]nonan-3-yl)acetate